Zai Lab's Zocilurtatug Pelitecan (Zoci, Formerly ZL-1310) Demonstrates High Response Rates, Encouraging Durability and Well-Tolerated Safety Profile in First-Line Extensive-Stage Small Cell Lung Cancer
– At the recommended Phase 3 dose (RP3D) of 1.6 mg/kg, zoci…
October 23, 2026
Coreline Soft Receives U.S. FDA 510(k) Clearance for AVIEW Aorta Metrics, Expanding Its Chest CT AI Portfolio in the U.S.
Secures its 13th FDA 510(k) clearance, expanding its U.S. portfolio from lung…